Priceline wasn’t the only big company interested in buying OpenTable before the online travel giant landed the coveted restaurant-reservation website in a $2.6 billion acquisition announced last month. OpenTable regulatory filings with the Securities and Exchange Commission revealed that seven companies, including Priceline (PCLN), talked with OpenTable before the company’s board accepted Priceline’s offer of $103 a share. The filings don’t
Verizon Communications has put out the word: It’s looking to add wireless spectrum in a government auction slated for mid-November. The outcome could well have a bearing on whether Verizon (VZ) will try to acquire spectrum from satellite-TV broadcaster Dish Network (DISH) or perhaps the whole company, analysts speculate. The Federal Communications Commission’s AWS-3, or Advanced Wireless Service No. 3, auction in November will be the first major
With the launch of Alprolix in May and Eloctate coming in July, Biogen Idec is on the leading edge of the first new class of hemophilia treatments to come along in 15 years. The question is, how interested are justifiably cautious patients in trying new things? Although hemophilia is fairly well-known due to its presence in some of Europe’s royal families, the disease is actually rare. Novo Nordisk (NVO) estimates that there are fewer than 500,000